Chronic Otitis Media Clinical Trial
— COMQ12-FROfficial title:
Validity of the French Version of the Quality of Life Questionnaire COMQ12-FR
Verified date | November 2022 |
Source | Assistance Publique - Hôpitaux de Paris |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The World Health Organization estimates that chronic otitis media could reach between 65 and 350 million people worldwide and thus be an important cause of medical consultation and prescription drugs. The medical care of chronic otitis is difficult, despite several medical and surgical treatment options. Moreover this pathology is gladly recurrent. The completion of a standardized questionnaire to track symptoms objectively over time is fundamental to verify the efficacy of specific treatments and to compare treatments. The quality of life measurement questionnaire related to chronic otitis media (COMQ-12) is a new questionnaire, validated in English, to assist the physician in evaluating chronic otitis media. The objective of this study is to translate and validate the test in French in children.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | July 2022 |
Est. primary completion date | July 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 7 Years to 15 Years |
Eligibility | Inclusion Criteria: - Minors aged 7 to 15 years (inclusive) - Patients with chronic otitis media, united or bilateral - Controls: subjects without chronic otitis media or any other pathology of the ear at the time of Inclusion or in background - holders of parental authority not opposed to participation in the study Exclusion Criteria: - Non-comprehension of french |
Country | Name | City | State |
---|---|---|---|
France | Hôpital Necker-Enfants Malades | Paris |
Lead Sponsor | Collaborator |
---|---|
Assistance Publique - Hôpitaux de Paris |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Reproducibility | Reproducibility of the questionnaire completed by a subject at 15 days apart. Student t-test. COMQ12 : Chronic Otitis Media Questionnaire 12. Score range from 0 to 110 (0 is the score in the absence of symptoms, 110 the worst possible). | 1 year | |
Primary | Consistency reliability test | Measure of efficiency. Comparison of questionnaires completed by patients and controls.
COMQ12 : Chronic Otitis Media Questionnaire 12. Score range from 0 to 110 (0 is the score in the absence of symptoms, 110 the worst possible). |
1 year | |
Primary | Item-total Pearson correlation | Measure of efficiency. Comparison of questionnaires completed by patients and controls.
COMQ12 : Chronic Otitis Media Questionnaire 12. Score range from 0 to 110 (0 is the score in the absence of symptoms, 110 the worst possible). |
1 year | |
Primary | Principal components analysis | Measure of efficiency. Comparison of questionnaires completed by patients and controls.
COMQ12 : Chronic Otitis Media Questionnaire 12. Score range from 0 to 110 (0 is the score in the absence of symptoms, 110 the worst possible). |
1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03294421 -
Combined Access Closed Tympanomastoidectomy: Microsurgery Allied to Endoscopy
|
N/A | |
Completed |
NCT01855425 -
Cone Beam CT for Diagnosis of Select Otorhinolaryngology (ENT) Indications at Lower Dose
|
N/A | |
Not yet recruiting |
NCT01157910 -
Bacterial Assessment of Middle Ear Fluid in Children Undergoing Ventilation Tube Placement Surgery
|
N/A | |
Completed |
NCT02226718 -
Validation of a Questionnaire for Measuring Quality of Life in Patients With Chronic Inflammation of the Middle Ear
|
||
Not yet recruiting |
NCT06398899 -
Sugammadex v.s. Neostigmine/Glycopyrrolate
|
N/A | |
Completed |
NCT02495038 -
Optimal Dose of Combination of Rocuronium and Cisatracurium
|
N/A | |
Completed |
NCT01251432 -
Risk Factors and Potential Causes of Eustachian Tube Dysfunction in Adults
|
N/A | |
Active, not recruiting |
NCT00271778 -
A Comparative Study of the Outcomes of 2 Surgical Procedures for Safe Type of Chronic Otitis Media
|
Phase 3 | |
Active, not recruiting |
NCT00270660 -
A Study of the Clinicopathologic Behaviour of the Different Types of Unsafe Chronic Otitis Media
|
Phase 3 | |
Completed |
NCT01188551 -
Dexmedetomidine Versus Fentanyl Following Pressure Equalization Tube Placement
|
Phase 2/Phase 3 | |
Completed |
NCT04374266 -
Tegmen Defect Management During Mastoidectomy
|
||
Completed |
NCT00189098 -
Effectiveness of Sulfamethoxazole-trimethoprim in the Treatment of Chronic Otitis Media
|
N/A | |
Completed |
NCT04864912 -
Retrospective Health Care Utilisation and Current Quality of Life in Adults With Chronic Otitis Media Who Had a Middle Ear Surgery
|
||
Active, not recruiting |
NCT04396145 -
The Effects of Chronic Otitis Surgery on SVV
|
||
Completed |
NCT02716376 -
Treatment and Prevention of Middle Ear Morbidity in Head and Neck Cancer Patients Following Radiotherapy
|
N/A | |
Completed |
NCT00941993 -
Anesthetic Effect of Lidocaine/Epinephrine Solution Delivered Via Iontophoresis to External Auditory Apparatus
|
N/A |